Gilead Sciences, Inc.

Christopher P Lee

James Ming Chen

Xiaowu Chen

Richard L Mackman

William John Watkins

Aesop Cho

Maria Fardis

Carina E Cannizzaro

Choung U Kim

Matthew A Williams

Hyung-Jung Pyun

Jennifer R Zhang

Lee Shun Chong

David A Oare

Alan X Huang

Constantine G Boojamra

Vidya K Prasad

Ralph F Hirschmann

Peter H Nelson

Manoj C Desai

Zheng-Yu Yang

Michael L Mitchell

Thorsten A Kirschberg

Adrian S Ray

Sundaramoorthi Swaminathan

William A Lee

David Y Markevitch

Haolun Jin

Rosemarie Sherlock

Kuei-Ying Lin

Lianhong Xu

Hongtao Liu

Lijun Zhang

Murty N Arimilli

Gong-Xin He

Steven H Krawczyk

Jianying Wang

Craig S Gibbs

Rosemarie O'Shea

Jiancun Zhang

James D Tario

Sundaramoorthi Swaninathan

Will Watkins

Richard H Yu

Mark Sparacino

Tanisha D Rowe

Azar Dastgah

Clifford Bryant

Mark M Becker

The invention is related to phosphorus substituted compounds with antiviral activity, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.

Antiviral phosphonate analogs

The invention is related to phosphorus substituted therapeutic agents, compositions containing such phosphorus substituted agents, and therapeutic methods that include the administration of such phosphorus substituted agents, as well as to processes and intermediates useful for preparing such agents.

Therapeutic phosphonate compounds

The invention is related to phosphonate substituted compounds having immuno-modulatory activity, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.

Phosphonate compounds having immuno-modulatory activity

Phosphorus-substituted imidazole compounds with anti-HIV properties having use as therapeutics and for other industrial purposes are disclosed. The compositions inhibit reverse transcriptase activity and are useful therapeutically for the inhibition of such enzymes, as well as in assays for the detection of such enzymes.

Non nucleoside reverse transcriptase inhibitors

The invention is related to phosphorus substituted anti-cancer compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.

Anti-cancer phosphonate analogs

The invention is related to phosphorus substituted anti-inflammatory compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.

Anti-inflammatory phosphonate compounds

Growing community of inventors

San Francisco, CA, United States of America

Christopher P Lee